Addressing Challenges in the Management of HoFH by Listening to Patients
Speakers: Jorge Plutzky, MD, Associate Professor of MedicineChristie M. Ballantyne, MD, Professor of Medicine
Duration: 60 minutes
Presented on: September 1, 2022
Jorge Plutzky, MD
Jorge Plutzky, MD
Associate Professor of Medicine
Christie M. Ballantyne, MD
Christie M. Ballantyne, MD
Professor of MedicineChristie M. Ballantyne, MD, is vice chair of research for the Department of Medicine, chief, sections of cardiology and cardiovascular research, and director of the Lipid Metabolism and Atherosclerosis Clinic Center for Cardiometabolic Disease Prevention at Baylor College of Medicine in Houston, Texas. Dr Ballantyne is a leading expert on lipids, atherosclerosis and heart disease prevention. He is an established investigator for the American Heart Association and receives funding from the National Institutes of Health for research and clinical trials. Dr Ballantyne is an editorial director for www.lipidsonline.org, serves on the editorial board for Circulation, and has published extensively on atherosclerosis, lipids and inflammation. He received his MD from Baylor College of Medicine.
Homozygous Familial Hypercholesterolemia: A Call to Action to Improve Diagnosis and Management
LEARNING OBJECTIVESAfter completing this activity, the participant should be better able to:
Jointly provided by Postgraduate Institute for Medicine and PlatformQ Health Education, LLC working in collaboration with the American Society for Preventive Cardiology (ASPC), and the Familial Hypercholesterolemia (FH) Foundation.
- Recognize the signs and symptoms of HoFH based on examination findings, low-density lipoprotein cholesterol (LDL-C) levels, and information from clinical and family histories
- Apply current guidelines for the management of HoFH, in terms of LDL-C targets and therapeutic approaches to LDL-C reduction
- Explain how, when added to conventional therapies, investigational agents with novel mechanisms of action or formulations can help reach LDL-C target goals and reduce non-LDL particles, while reducing the need for apheresis in adults and children
ACKNOWLEDGEMENTSupported by an educational grant from Novartis and Regeneron.
JOINT ACCREDITATION STATEMENTIn support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
LIVE CREDIT DESIGNATION STATEMENTThe Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ENDURING CREDIT DESIGNATION STATEMENTThe Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DATE OF RELEASE/EXPIRATION
Live ActivityTuesday, July 20, 2021 at 2:00-3:00pm EST
Enduring MaterialJuly 20, 2021 – July 20, 2022.
TARGET AUDIENCEThe intended audience for this activity program are cardiologists, PCPs, lipidologists, and endocrinologists.
ESTIMATED TIME TO COMPLETEThis activity should take approximately 1 hour to complete.
METHOD OF PARTICIPATIONThere are no fees to participate in this activity. To participate in the activity, go to www.CardioCareLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.
HARDWARE/SOFTWARE REQUIREMENTSParticipants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
DISCLOSURE OF CONFLICTS OF INTERESTPostgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Faculty or Presenter Reported Financial Relationship Peter P. Toth, MD, PhD, FCCP, FASPC, FAHA, FESC, FACC
Director of Preventative Cardiology
CGH Medical Center
Professor of Clinical Family and Community Medicine
University of Illinois College of Medicine
Professor of Clinical Medicine
Michigan State University College of Osteopathic Medicine
East Lansing, Michigan
Adjunct Associate Professor Medicine
Johns Hopkins University School of Medicine
President, American Society for Preventive Cardiology
Consulting Fees (e.g advisory boards): Amarin, bio89, Kowa, Novartis, and Theravance
Fees for Non-CE Services Received Directly from an Ineligible Entity or their Agents (e.g speakers’ bureaus): Amgen, Esperion, Mereck, Novo-Nordisk
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, FACP, FCCP
Harvard Medical School
Interventional Cardiovascular Programs
Brigham and Women's Hospital Heart and Vascular Center
Contracted Research: Abbott, Afimmune, Amarin, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Cardax, CellProthera, Cereno Scientific, Chiesi, CSL Behring, Eisai, Ethicon, Ferring Pharmaceuticals, Forest Laboratories, Fractyl, Garmin, HLS Therapeutics, Idorsia, Ironwood, Ischemix, Janssen, Lexicon, Lilly, Medtronic, MyoKardia, NirvaMed, Novartis, Novo Nordisk, Owkin, Pfizer, PhaseBio, PLx Pharma, Regeneron, Roche, Sanofi, Synaptic, The Medicines Company, and 89Bio
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Faculty or Presenter Reported Financial Relationship Carole Drexel
PlatformQ Health Education, LLC
The PIM planners and managers have nothing to disclose.
The following PlatformQ Health Education, LLC planner, Bridget Griffin, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER:Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
CONTACT INFORMATIONAccreditation Support: Please contact the Postgraduate Institute for Medicine at firstname.lastname@example.org.
Technical Support: For any technical issues or issues with your CME Certificate, please contact CardioCareLive at 877-394-1306 or at Support@CardioCareLive.com.